GOLDBERG, M. S.; SIEGEL, J. J.; AHMED, K.; KURLEY, S. J.; FARBERG, A. S. A prospective clinical utility study demonstrates that physicians use the 40-gene expression profile (40-GEP) to guide clinical management decisions for Medicare-eligible patients with cutaneous squamous cell carcinoma (cSCC). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s95, 2022. DOI: 10.25251/skin.6.supp.95. Disponível em: https://jofskin.org/index.php/skin/article/view/1854. Acesso em: 22 jul. 2024.